Australian made Global Solutions
Developing and manufacturing point-of-care tests for infectious diseases
To provide rapid, accurate and low-cost tests to meet global diagnostic needs
Launched in 2019, ZiP Diagnostics is an Australian owned, Melbourne based biotech company focused on domestic manufacture of low-cost solutions for infectious diseases point-of-care diagnostics.
ZiP has its headquarters, laboratory and production facilities in Collingwood, Victoria. All significant components of the test system are domestically produced including assays, cartridges and instruments.
ZiP works under a ISO13485 compliant quality management system.
Meet the Leadership Team
Dr Jack Richards
Australian Government, Department of Defence, Science and Technology
Axxin Pty Ltd
Biochemistry, Cell and Molecular Biology (BCMB), University of Ghana.
Commonwealth Scientific and Industrial Research (CSIRO)
Foundation for Innovative New Diagnostics (FIND)
Noguchi Memorial Institute for Medical Research (NMIMR), University of Ghana.
Royal Melbourne Hospital
Victorian Infectious Diseases Reference Laboratory (VIDRL)
Walter and Eliza Hall Institute of Medical Research (WEHI)
West African Centre for Cell Biology of Infectious Pathogens (WACBIP), University of Ghana.
ZiP Diagnostics has been announced as one of the successful recipients of the Department of Industry, Science and Technology, Accelerating Commercialisation grants scheme...
ZiP Diagnostics is bringing a high sensitivity molecular test system for
SARS-CoV-2 to domestic high-volume production.
ZiP Diagnostics is looking for volunteers aged 18 years and over to provide periodic donation of samples (swabs, saliva, urine or blood) over a 12 month period.